Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1

Adeno-associated viruses (AAV) have been developed and evaluated as recombinant vectors for gene therapy in many preclinical studies, as well as in clinical trials. However, only a few approaches have used recombinant AAV (rAAV) to deliver vaccine antigens. We generated an rAAV encoding the major ca...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kuck, Dirk, Lau, Tobias, Leuchs, Barbara, Kern, Andrea, Müller, Martin, Gissmann, Lutz, Kleinschmidt, Jürgen A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2006
Aiheet:
Vaccines and Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1395428/
https://ncbi.nlm.nih.gov/pubmed/16501072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.80.6.2621-2630.2006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia